118.79
price down icon0.33%   -0.3712
 
loading
Schlusskurs vom Vortag:
$119.16
Offen:
$119.04
24-Stunden-Volumen:
579.87K
Relative Volume:
0.65
Marktkapitalisierung:
$14.40B
Einnahmen:
$2.72B
Nettoeinkommen (Verlust:
$254.30M
KGV:
57.48
EPS:
2.0665
Netto-Cashflow:
$564.37M
1W Leistung:
-5.83%
1M Leistung:
+1.86%
6M Leistung:
+2.71%
1J Leistung:
+15.43%
1-Tages-Spanne:
Value
$116.63
$119.72
1-Wochen-Bereich:
Value
$116.63
$126.57
52-Wochen-Spanne:
Value
$97.31
$129.50

Revvity Inc Stock (RVTY) Company Profile

Name
Firmenname
Revvity Inc
Name
Telefon
781-663-6900
Name
Adresse
77 4TH AVENUE, WALTHAM
Name
Mitarbeiter
11,500
Name
Twitter
Name
Nächster Verdiensttermin
2025-01-31
Name
Neueste SEC-Einreichungen
Name
RVTY's Discussions on Twitter

Vergleichen Sie RVTY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
RVTY
Revvity Inc
118.78 14.40B 2.72B 254.30M 564.37M 2.0665
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
571.77 218.67B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
205.87 148.44B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
A
Agilent Technologies Inc
145.78 41.57B 6.51B 1.29B 1.37B 4.42
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
458.77 37.56B 3.84B 866.24M 792.60M 10.37
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
207.93 36.56B 15.32B 1.41B 1.96B 7.62

Revvity Inc Stock (RVTY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-10 Herabstufung Bernstein Outperform → Mkt Perform
2024-12-13 Hochstufung BofA Securities Neutral → Buy
2024-10-15 Hochstufung Barclays Equal Weight → Overweight
2024-08-28 Eingeleitet Wells Fargo Equal Weight
2024-07-08 Eingeleitet Leerink Partners Outperform
2024-06-03 Fortgesetzt Jefferies Hold
2024-01-16 Herabstufung UBS Buy → Neutral
2024-01-04 Hochstufung Evercore ISI In-line → Outperform
2023-12-19 Eingeleitet Wells Fargo Equal Weight
2023-12-13 Eingeleitet Wolfe Research Peer Perform
2023-09-28 Eingeleitet Bernstein Outperform
2023-07-19 Eingeleitet Raymond James Outperform
2023-05-23 Fortgesetzt Goldman Buy
Alle ansehen

Revvity Inc Aktie (RVTY) Neueste Nachrichten

pulisher
01:13 AM

KeyCorp Forecasts Strong Price Appreciation for Revvity (NYSE:RVTY) Stock - MarketBeat

01:13 AM
pulisher
Feb 06, 2025

Revvity Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Feb 06, 2025
pulisher
Feb 06, 2025

Trust Point Inc. Purchases Shares of 4,594 Revvity, Inc. (NYSE:RVTY) - MarketBeat

Feb 06, 2025
pulisher
Feb 05, 2025

Barclays Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat

Feb 05, 2025
pulisher
Feb 04, 2025

Revvity (NYSE:RVTY) Updates FY 2025 Earnings Guidance - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Jefferies raises Revvity stock price target to $130, maintains Hold - MSN

Feb 04, 2025
pulisher
Feb 04, 2025

Revvity anticipates 3%-5% organic growth in 2025 amid market stabilization - MSN

Feb 04, 2025
pulisher
Feb 04, 2025

Revvity, Inc. (NYSE:RVTY) Insider Joel S. Goldberg Sells 15,170 Shares - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Revvity’s Strong Recurring Revenue and Growth Prospects Justify Buy Rating - TipRanks

Feb 04, 2025
pulisher
Feb 04, 2025

Exchange Traded Concepts LLC Sells 3,502 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

Raymond James Adjusts Price Target on Revvity to $145 From $140 -February 03, 2025 at 11:43 am EST - Marketscreener.com

Feb 03, 2025
pulisher
Feb 03, 2025

KeyBanc Adjusts Revvity Price Target to $145 From $132 -February 03, 2025 at 11:26 am EST - Marketscreener.com

Feb 03, 2025
pulisher
Feb 03, 2025

Revvity (NYSE:RVTY) Receives "Outperform" Rating from Raymond James - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

Revvity (RVTY) Reports Q4 Earnings: What Key Metrics Have to Say - MSN

Feb 03, 2025
pulisher
Feb 02, 2025

Revvity, Inc. (NYSE:RVTY) Q4 2024 Earnings Call Transcript - MSN

Feb 02, 2025
pulisher
Feb 02, 2025

Revvity shares leap over 5% as Q4 earnings top estimates - MSN

Feb 02, 2025
pulisher
Feb 01, 2025

Revvity (RVTY) Surpasses Q4 Earnings Estimates - MSN

Feb 01, 2025
pulisher
Feb 01, 2025

Revvity’s Strong Q4 Performance and 2025 Outlook - TipRanks

Feb 01, 2025
pulisher
Feb 01, 2025

Revvity (NYSE:RVTY) Releases Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat

Feb 01, 2025
pulisher
Feb 01, 2025

Earnings call transcript: Revvity Q4 2024 shows steady growth amid mixed market reaction - MSN

Feb 01, 2025
pulisher
Feb 01, 2025

Jefferies raises Revvity stock price target to $130, maintains Hold By Investing.com - Investing.com Australia

Feb 01, 2025
pulisher
Feb 01, 2025

Revvity Inc (RVTY) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ... - Yahoo Finance

Feb 01, 2025
pulisher
Jan 31, 2025

Revvity Reports Positive 2024 Financial Results - TipRanks

Jan 31, 2025
pulisher
Jan 31, 2025

Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations By Stock Story - Investing.com Canada

Jan 31, 2025
pulisher
Jan 31, 2025

Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations - Yahoo Finance

Jan 31, 2025
pulisher
Jan 31, 2025

RVTY Q4 Earnings Beat Estimates, Sales Miss, Segments Robust - MSN

Jan 31, 2025
pulisher
Jan 31, 2025

Revvity's 2025 Guidance Signals Cautious Optimism Amid Slower-Than-Expected Pharma Spending Recovery - Morningstar

Jan 31, 2025
pulisher
Jan 31, 2025

Citigroup Raises Price Target on Revvity to $155 From $145 -January 31, 2025 at 02:24 pm EST - Marketscreener.com

Jan 31, 2025
pulisher
Jan 31, 2025

Evercore ISI Adjusts Price Target on Revvity to $138 From $125 -January 31, 2025 at 11:35 am EST - Marketscreener.com

Jan 31, 2025
pulisher
Jan 31, 2025

Revvity Predicts Lower 2025 Earnings Despite Strong Fourth Quarter - Finimize

Jan 31, 2025
pulisher
Jan 31, 2025

Revvity: Q4 Earnings Snapshot - Houston Chronicle

Jan 31, 2025
pulisher
Jan 31, 2025

Revvity forecasts 2025 revenue, profit below estimates amid weak biotech spending - MSN

Jan 31, 2025
pulisher
Jan 31, 2025

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024 - BioSpace

Jan 31, 2025
pulisher
Jan 31, 2025

Revvity Inc (RVTY) Q4 2024 Earnings: EPS of $0.78 Beats Estimates, Revenue Hits $729 Million - GuruFocus.com

Jan 31, 2025

Finanzdaten der Revvity Inc-Aktie (RVTY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research DGX
$162.21
price down icon 0.22%
diagnostics_research LH
$246.28
price down icon 0.54%
$171.82
price down icon 1.84%
diagnostics_research WAT
$407.64
price down icon 0.84%
diagnostics_research MTD
$1,421.36
price up icon 3.89%
diagnostics_research IQV
$207.62
price down icon 1.13%
Kapitalisierung:     |  Volumen (24h):